Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$1.05 - $1.63 $11,210 - $17,403
10,677 New
10,677 $12,000
Q2 2022

Jul 25, 2022

SELL
$2.13 - $9.01 $15,894 - $67,232
-7,462 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$6.28 - $15.59 $35,475 - $88,067
-5,649 Reduced 43.09%
7,462 $59,000
Q4 2021

Jan 28, 2022

BUY
$14.7 - $28.67 $192,731 - $375,892
13,111 New
13,111 $200,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.